Bitget App
Trade smarter
Acheter des cryptosMarchésTradingFuturesEarnCommunautéPlus
Prix
Données
À propos
INSM stock price forecast
Concurrents
Tokenisation
Crypto
FAQ
Logo action Insmed Incorporated

Insmed Incorporated

INSM·NASDAQ

Dernière mise à jour : 2026-02-12 16:22 EST. Les données sur les prix des actions proviennent de TradingView et reflètent les prix du marché en temps réel.

Insights
Calculateur
Actualités

Variation du cours des actions INSM

Le dernier jour de trading, l'action INSM a clôturé à 145.52 USD, avec une variation de prix de -2.04% pour la journée.
Trader des Futures sur actions

À propos de Bitget

La première plateforme d'échange (UEX) au monde, permettant aux utilisateurs de trader non seulement des cryptomonnaies, mais aussi des actions, des ETF, le Forex, l'or et des actifs du monde réel (RWA).
En savoir plus

INSM – Données clés

Clôture précédente145.52 USD
Capitalisation31.04B USD
Volume304.47K
Ratio P/E-
Rendement du dividende (sur 12 mois)0.00%
Montant du dividende-
Dernière date de détachement-
Date du dernier paiement-
BPA dilué (sur 12 mois)-6.18 USD
Résultat net (ex. financier)−913.77M USD
Chiffre d'affaires (ex. financier)363.71M USD
Date du prochain rapportFeb 19, 2026
Estimation du BPA-
Chiffre d'affaires estimé233.16M USD USD
Actions en circulation210.34M
Bêta (1Y)0.53
Tokenized stocks

Avez-vous déjà entendu parler des actions tokenisées ?

Une nouvelle façon de trader des actions – n'importe où, 24h/7j

En savoir plus

Insmed Incorporated – Vue d'ensemble

Insmed, Inc. est une société biopharmaceutique mondiale spécialisée dans le développement et la commercialisation de traitements pour les patients atteints de maladies rares. Elle se concentre sur Brensocatib et Treprostinil Palmitil Inhalation Powder (TPIP) dans son portefeuille de produits. Fondée en 1988, l’entreprise a son siège à Bridgewater, New Jersey.
Secteur
Technologie de la santé
Secteur d'activité
Pharmaceutique : grandes entreprises
CEO
William H. Lewis
Siège social
Bridgewater
Site web
insmed.com
Création
1988
Employés (ex. financier)
1.27K
Variation (1 an)
+359 +39.36%
Chiffre d'affaires / Employé (1Y)
286.16K USD
Résultat net / Employé (1Y)
−718.94K USD

Baromètre INSM en temps réel

Daily updates on INSM stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• Variation du cours de l'action INSM sur 24h : -0,66 %. De 149,54 USD à 148,55 USD. Ce léger recul reflète une consolidation à court terme et une pression de vente interne récente, malgré une perspective de croissance à long terme solide.
• D'un point de vue technique, INSM est actuellement en « correction baissière à court terme » : le titre évolue sous ses moyennes mobiles sur 20 jours (159,27 $) et 50 jours (172,50 $), avec un RSI neutre de 34-39 indiquant une approche de la zone de survente mais sans élan haussier immédiat.
• Goldman Sachs a maintenu sa recommandation « Acheter » le 11 février, en relevant l'objectif de cours de 225 $ à 230 $, citant sa confiance dans le portefeuille de maladies rares de la société et les prochaines autorisations de brensocatib.
• Les derniers dépôts auprès de la SEC révèlent des ventes d'actions coordonnées par les dirigeants d'Insmed, dont le PDG et le directeur financier, ce qui a contribué à une prudence accrue des investisseurs à court terme.
• Les données historiques montrent qu'INSM connaît souvent un « rallye pré-résultats », avec une hausse du titre dans 75 % des cas la semaine précédant la prochaine publication de résultats prévue le 19 février 2026.
• La FDA a adressé une lettre de « refusal-to-file » à Moderna pour son vaccin contre la grippe à base d'ARNm le 10 février, soulignant un contrôle réglementaire renforcé et générant de la volatilité dans l'ensemble du secteur biotechnologique.
• L'incertitude sur le marché des biotechnologies s'accroît après les avertissements d'anciens responsables de la FDA concernant de possibles incohérences dans les standards d'approbation des médicaments, liées à des changements politiques et administratifs.
Voir plus
il y a 1j
• Variation du cours de l'action INSM sur 24h : -0,21 %. De 149,86 USD à 149,54 USD. Ce léger recul reflète une phase de consolidation après la récente faiblesse du titre et une série de ventes d’actions par des cadres dirigeants.
• D’un point de vue technique, l’action évolue dans une phase baissière à court terme tout en conservant un support à long terme. Elle se négocie actuellement sous sa moyenne mobile à 50 jours (173,66 USD), mais reste au-dessus de sa moyenne mobile ascendante à 200 jours (161,05 USD), avec un RSI à 34,5 indiquant une proximité de la zone de survente.
• Insmed a annoncé la publication de ses résultats financiers du quatrième trimestre et de l’exercice 2025 le 19 février 2026, date à laquelle des mises à jour majeures sont attendues concernant son portefeuille brensocatib.
• Plusieurs hauts dirigeants, dont le PDG William Lewis, la directrice financière Sara Bonstein et le directeur juridique, ont procédé à des ventes coordonnées d’actions début février, pour un montant total de plus de 1,7 million de dollars en une seule semaine.
• L’activité institutionnelle reste contrastée : Envestnet Asset Management a réduit sa position, tandis que FORSTA AP-FONDEN a récemment ouvert une nouvelle position de 7,8 millions de dollars sur le titre.
• Eli Lilly a conclu un accord pour acquérir le développeur de CAR-T in vivo Orna Therapeutics pour un montant pouvant atteindre 2,4 milliards de dollars, témoignant d’un appétit soutenu pour les opérations de M&A à forte valeur dans le secteur biotechnologique.
• La FDA a publié une demande d’informations concernant l’étiquetage du gluten dans les aliments emballés, soulignant ce mois-ci un renforcement de la réglementation sur la transparence des ingrédients et les traitements des maladies rares.
Voir plus
il y a 2j

INSM stock price forecast

According to technical indicators for INSM stock, the price is likely to fluctuate within the range of 161.89–169.78 USD over the next week. Market analysts predict that the price of INSM stock will likely fluctuate within the range of 135.39–176.79 USD over the next months.

Based on 1-year price forecasts from 70 analysts, the highest estimate is 349.82 USD, while the lowest estimate is 130.67 USD.

For more information, please see the INSM stock price forecast Stock Price Forecast page.

Avec un simple compte Bitget, vous pouvez trader simultanément des actions et des cryptomonnaies.

Participer maintenant

FAQ

Quel est le cours de l'action Insmed Incorporated ?

INSM a actuellement un prix de 145.52 USD. Son cours a varié de -2.04% au cours des dernières 24h. Vous pouvez suivre de plus près l'évolution du cours de l'action Insmed Incorporated sur le graphique de prix en haut de cette page.

Quel est le symbole boursier de Insmed Incorporated ?

Selon la plateforme, le symbole boursier peut varier. Par exemple, sur NASDAQ, Insmed Incorporated est tradé sous le symbole INSM.

Quelles sont les prévisions pour les actions INSM ?

Nous avons recueilli des avis d'analystes sur le cours futur de Insmed Incorporated. Selon leurs prévisions, INSM a une estimation maximale de 1455.20 USD et une estimation minimale de 291.04 USD.

Quelle est la capitalisation boursière de Insmed Incorporated ?

Insmed Incorporated a une capitalisation boursière de 31.04B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Avertissement sur les risques:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommandation : les activités promotionnelles pouvant être modifiées ou interrompues à tout moment, veuillez consulter les pages officielles " Fee overview " ou " Announcement Center " de Bitget pour connaître les taux les plus récents et les plus précis au moment du trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NASDAQ/
INSM
Bitget© 2026